Manchester Capital Management LLC Bio Techne Corp Transaction History

Manchester Capital Management LLC

$829 Million
Q3 2024

A detailed history of Manchester Capital Management LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Manchester Capital Management LLC holds 2,127 shares of TECH stock, worth $155,334. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,127

Previous 2,007 5.98%

Holding current value

$155,334

Previous $143,000 18.18%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$70.96 - $82.35 $8,515 - $9,882	120 Added 5.98%	2,127 $169,000
Q2 2024 Aug 08, 2024	BUY	$62.12 - $84.15 $16,648 - $22,552	268 Added 15.41%	2,007 $143,000
Q1 2024 May 06, 2024	BUY	$65.98 - $77.09 $111,044 - $129,742	1,683 Added 3005.36%	1,739 $122,000
Q4 2023 Feb 08, 2024	SELL	$52.83 - $78.22 $86,007 - $127,342	-1,628 Reduced 96.67%	56 $4,000
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $20,947 - $24,418	284 Added 20.29%	1,684 $137,000
Q1 2023 May 09, 2023	BUY	$71.62 - $86.62 $100,268 - $121,268	1,400 New	1,400 $103,000
Q2 2022 Aug 10, 2022	SELL	$322.67 - $449.65 $29,040 - $40,468	-90 Reduced 22.5%	310 $107,000
Q4 2021 Feb 10, 2022	BUY	$456.15 - $525.06 $20,526 - $23,627	45 Added 12.68%	400 $207,000
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $155,259 - $188,069	349 Added 5816.67%	355 $172,000
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $2,324 - $2,701	6 New	6 $3,000
Q1 2021 May 13, 2021	SELL	$314.62 - $411.0 $943 - $1,233	-3 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $740 - $965	3 New	3 $1,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.86B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.

Account

Manchester Capital Management LLC Bio Techne Corp Transaction History